← Home
The All-In Podcast · May 8, 2026 · 1h 22m
Elon's Anthropic Deal, The Next AI Monopoly?, "FDA for AI" Panic, Trading the AI Boom
The All-In besties debate Elon's SpaceX-Anthropic compute partnership, whether Anthropic is becoming an AI monopoly, White House "FDA for AI" regulation talk, and opportunities in AI market trading. Discussion spans infrastructure economics, antitrust concerns, policy risks to AI innovation, and how AI is shifting from a negative perception problem to a positive impact play in healthcare and education.
This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.
Highlights
•
•
Editorial
•
•
AI's Perception Problem Is Solvable Via Concrete Impact01:00:04
The group argues that AI's current negative public perception — tied to job displacement, safety risks, misuse — can be reversed by shipping wins in healthcare diagnostics, education personalization, and other high-impact domains.Misc
✧Elon moving compute deal from xAI to Anthropic signals strategic shift in AI landscape
✧Besties note Anthropic's growth is "insane" — suggests exponential trajectory worth watching
✧SpaceX IPO valuation discussion ties infrastructure investment to AI compute needs
✧White House National Policy Framework for AI causes genuine market anxiety among investors
✧Group consensus: AI's perception problem is solvable via concrete wins (healthcare, education)
Was this useful?